Dong Chen

Human Organoids as a Promising Platform for Fighting COVID-19

Wei Wei, Dong Chen, Xingping Su, 2022, International journal of biological sciences.

SARS-CoV-2 is less likely to infect aquatic food animals: sequence and phylogeny analysis of ACE2 in mammals and fish

Yuchen Liu, Weiren Huang, Huihui Yang, 2020, Molecular Biomedicine.

Patient‐derived organoids of bladder cancer recapitulate antigen expression profiles and serve as a personal evaluation model for CAR‐T cells in vitro

Weiren Huang, Zhongfu Zhang, Wei Chen, 2021, Clinical & translational immunology.

Protocol for generation of lung adenocarcinoma organoids from clinical samples

Weiren Huang, Wei Chen, Dong Chen, 2020, STAR protocols.

Papillary thyroid cancer organoids harboring BRAFV600E mutation reveal potentially beneficial effects of BRAF inhibitor-based combination therapies

Hao Yang, Peng Li, Wei Wei, 2023, Journal of Translational Medicine.

Organoid cultures derived from patients with papillary thyroid cancer.

Yuchen Liu, Weiren Huang, Wei Chen, 2021, The Journal of clinical endocrinology and metabolism.

Establishment of papillary thyroid cancer organoid lines from clinical specimens

Jian Zhang, Hao Yang, Dong Chen, 2023, Frontiers in Endocrinology.

Oxypalmatine regulates proliferation and apoptosis of breast cancer cells by inhibiting PI3K/AKT signaling and its efficacy against breast cancer organoids.

Xian Lin, Xinyu Chu, Lianxiang Luo, 2023, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Dimeric oxyberberine CT4-1 targets LINC02331 to induce cytotoxicity and inhibit chemoresistance via suppressing Wnt/β-catenin signaling in hepatocellular carcinoma

X. Li, Kaixuan Luo, Zunnan Huang, 2023, Archives of Toxicology.

Organoid models derived from patients with malignant phyllodes tumor of the breast

Xinyu Chu, Dong Chen, Jinsong He, 2023, Breast Cancer Research and Treatment.